Portfolio 1 - New Portfolio

John Bender

Portfolio 1
Individual Investor
Ranked #202,780 out of 767,017 TipRanks' Investors
Success Rate
53%
135 out of 253
profitable transactions
Average Return
17.05%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 6.89%
6-Month Return▲ 11.40%
12-Month Return▲ 49.71%
YTD Return▲ 22.06%
Total Return▲ 132.57%

Best Trade

Opened at
Closed at
Gain▲ 538.65%

Bio

Income-focused Retirement Portfolio with speculative bio/pharma, EV and space positions

Performance

25.72%0-25.72%
▼ 12.40%
▼ 4.03%
▼ 7.50%
Apr 2024
▲ 11.46%
▲ 5.06%
▲ 7.40%
May 2024
▼ 2.25%
▲ 3.53%
▼ 4.35%
Jun 2024
▲ 25.72%
▲ 1.21%
▲ 8.72%
Jul 2024
▼ 4.22%
▲ 2.34%
▼ 3.89%
Aug 2024
▲ 7.82%
▲ 2.10%
▲ 5.00%
Sep 2024
▲ 6.02%
▼ 0.89%
▼ 0.41%
Oct 2024
▲ 9.99%
▲ 4.97%
▲ 7.70%
Nov 2024
TipRanks AverageS&P 500Investor Portfolio
▼ 12.40%▼ 4.03%▼ 7.50%
▲ 11.46%▲ 5.06%▲ 7.40%
▼ 2.25%▲ 3.53%▼ 4.35%
▲ 25.72%▲ 1.21%▲ 8.72%
▼ 4.22%▲ 2.34%▼ 3.89%
▲ 7.82%▲ 2.10%▲ 5.00%
▲ 6.02%▼ 0.89%▼ 0.41%
▲ 9.99%▲ 4.97%▲ 7.70%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Terran Orbital Corp
▼ 83.89%
2
Close
Aug 21, 2024
Atara Biotherapeutics
▼ 94.80%
4
Close
Feb 18, 2024
Agenus
▼ 83.14%
3
Close
Feb 18, 2024
Carnival
▼ 5.19%
4
Close
Feb 18, 2024
ImmunoGen
▲ 538.65%
4
Close
Feb 18, 2024
Caribou Biosciences
▼ 29.06%
2
Close
Feb 18, 2024
Crinetics Pharmaceuticals
▲ 104.88%
2
Close
Feb 18, 2024
Cyclo Therapeutics
▼ 6.88%
2
Close
Feb 18, 2024
Precision BioSciences
▼ 71.79%
3
Close
Feb 18, 2024
Capital Southwest
▲ 45.75%
2
Close
Feb 18, 2024
Axsome Therapeutics
▲ 105.56%
3
Close
Feb 18, 2024
Spyre Therapeutics
▼ 9.83%
2
Close
Feb 18, 2024
Allogene Therapeutics
▼ 38.85%
3
Close
Feb 18, 2024
Alpine Immune Sciences
▲ 428.93%
2
Close
Feb 18, 2024
Altimmune
▲ 23.95%
3
Close
Feb 18, 2024
ProShares MSCI Transformational Changes ETF
▲ 31.56%
2
Close
Feb 18, 2024
ARK Innovation ETF
▲ 31.48%
3
Close
Feb 18, 2024
Arcutis Biotherapeutics
▼ 41.09%
3
Close
Feb 18, 2024
Astra Space
▼ 79.27%
3
Close
Feb 18, 2024
Anavex Life Sciences
▼ 53.41%
2
Close
Feb 18, 2024